Individual data of the participants
| Patient | Age | Sex | Diagnosis | Setting | Medication | ΔHAMD |
|---|---|---|---|---|---|---|
| Diagnosis: 1, major depressive disorder, single episode, moderate; 2, major depressive disorder, recurrent, moderate; 3, bipolar I disorder, most recent episode depressed, moderate; 4, bipolar I disorder, most recent episode depressed, severe; 5, dysthymic disorder. | ||||||
| Medication: 1, lithium carbonate; 2, carbamazepine; 3, tricyclic antidepressant; 4, selective serotonin reuptake inhibitor (SSRI); 5, monoaminooxidase inhibitors; 6, l-thyroxine; 7, neuroleptic; 8, sedative. | ||||||
| ΔHAMD, Reduction in the Hamilton Rating Scale of Depression between both assessments before and at the end of the training programme. | ||||||
| 1 | 59 | f | 3 | Outpatient | 1,2,4,6 | −8 |
| 2 | 46 | m | 2,5 | Outpatient | 1,3 | −5 |
| 3 | 36 | m | 2 | Outpatient | 3 | 0 |
| 4 | 42 | f | 1,5 | Outpatient | 6,7,4 | −2 |
| 5 | 48 | f | 2 | Outpatient | 3,6 | −8 |
| 6 | 28 | m | 2 | Outpatient | 3,4,7 | −15 |
| 7 | 64 | m | 2 | Outpatient | 1 | −2 |
| 8 | 58 | m | 4 | Inpatient | 1,7,8 | −14 |
| 9 | 58 | f | 4 | Inpatient | 1,2 | −14 |
| 10 | 49 | f | 2 | Inpatient | 1,7 | −6 |
| 11 | 56 | f | 2 | Inpatient | 1,5 | −3 |
| 12 | 56 | f | 4 | Inpatient | 6,7 | 0 |